SCHEMBL18376643

SCHEMBL18376643

COc1ccc(-c2cccc3nc(N)ncc23)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.58
ADORA2A P29274 4/20 0.56
MAPT P10636 4/20 0.50
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
MAPK10 P53779 1/20 0.50
PTK2B Q14289 1/20 0.50
NCOA1 Q15788 1/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
ACACA Q13085 1/20 0.49
ADORA1 P30542 1/20 0.48
CYP1A1 P04798 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP1B1 Q16678 1/20 0.48
NPSR1 Q6W5P4 2/20 0.47
LMNA P02545 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29368241 1.00 KMT2A (0.58) KMT2AADORA2AMAPTTP53TSHR
SCHEMBL29372601 0.78 KMT2A (0.60) KMT2AADORA2AMAPTTP53TSHR
SCHEMBL18376867 0.78 KMT2A (0.60) KMT2AADORA2AMAPTTP53TSHR
SCHEMBL18376635 0.78 PTGS2 (0.50)
SCHEMBL29371782 0.78 PTGS2 (0.50)
SCHEMBL30482737 0.75 DHFR (0.61) KMT2AADORA2ACYP1A1CYP1A2CYP1B1
SCHEMBL264291 0.75 KMT2A (0.73) KMT2AMAPTTP53TSHRMAPK1
SCHEMBL30488020 0.75 KMT2A (0.73) KMT2AMAPTTP53TSHRMAPK1
SCHEMBL29205101 0.75 MERTK (0.45) KMT2AMAPTTP53TSHRMAPK1
SCHEMBL18376580 0.74 JAK1 (0.53) PTK2BLMNACDC25ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 CN claimed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 WO disclosed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 CN disclosed